Novel Molecular Imaging & Radiopharmaceutical Development

Session details:

Radiopharmaceuticals and molecular imaging approaches are creating new opportunities to visualize tumor biology, improve patient selection, and guide treatment strategies. As radioligand therapies continue to expand across oncology, imaging is becoming increasingly important in both drug development and clinical application. Key Topics:

• Emerging molecular imaging targets in oncology
• The growing role of radiotheranostics in cancer drug development
• Companion imaging approaches for radioligand therapies
• Patient selection and treatment monitoring strategies
• Opportunities to combine radiopharmaceuticals with immuno-oncology approaches